 |
| Evonik is one of the world's leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of our strategy, which is supported by its owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent). Evonik's specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalization—and its goal is to enter attractive future-oriented markets. Click on the image to visit the Evonik website. |
